Showing results (1271-1280 of 1,323) with videos related to

Sort By:
Pageof 133
Sleep|December 16, 2025
High OSA hypoxic burden associates with reduced locus coeruleus structural integrity on 7T MRI in older adultsKorey Kam, Naomi L Gaggi, Ankit Parekh, et al.
The Lancet. Infectious Diseases|October 20, 2018
Outbreak of Neisseria meningitidis serogroup C outside the meningitis belt-Liberia, 2017: an epidemiological and laboratory investigationCatherine H Bozio, Jeni Vuong, E Kainne Dokubo, et al.
Emerging Infectious Diseases|January 27, 2016
Ebola and Its Control in Liberia, 2014-2015Tolbert G Nyenswah, Francis Kateh, Luke Bawo, et al.
American Journal of Respiratory and Critical Care Medicine|July 30, 2025
Research Priorities for Translating Endophenotyping of Adult Obstructive Sleep Apnea to the Clinic: An Official American Thoracic Society Research StatementThomas M Tolbert, Christopher N Schmickl, Laura K Gell, et al.
The Pan African Medical Journal|August 13, 2019
Enhancing laboratory capacity during Ebola virus disease (EVD) heightened surveillance in Liberia: lessons learned and recommendationsVictoria Katawera, Henry Kohar, Nuha Mahmoud, et al.
Plos Medicine|January 25, 2017
Bolstering Community Cooperation in Ebola Resurgence Protocols: Combining Field Blood Draw and Point-of-Care DiagnosisMosoka P Fallah, Laura A Skrip, Philomena Raftery, et al.
Biorxiv : the Preprint Server for Biology|August 10, 2021
Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of ConcernWenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Journal of Virology|October 13, 2025
Optimization of VE607 to generate analogs with improved neutralization activities against SARS-CoV-2 variantsShilei Ding, Derek Yang, Irfan Ullah, et al.
Blood|September 22, 2025
Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 studyAjai Chari, Niels W C J van de Donk, Bhagirathbhai Dholaria, et al.
Cell Reports|December 31, 2021
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concernWenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Pageof 133